Table of Contents Europe Diabetic Therapeutic Drugs Market Report 2012-2023 1 Diabetic Therapeutic Drugs Overview 1.1 Product Overview and Scope of Diabetic Therapeutic Drugs 1.2 Classification of Diabetic Therapeutic Drugs by Product Category 1.2.1 Europe Diabetic Therapeutic Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Diabetic Therapeutic Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Insulin Therapies 1.2.4 Non-Insulin Therapies 1.3 Europe Diabetic Therapeutic Drugs Market by Application/End Users 1.3.1 Europe Diabetic Therapeutic Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Type 1 Diabetes 1.3.3 Type 2 Diabetes 1.3.4 Gestational Diabetes 1.4 Europe Diabetic Therapeutic Drugs Market by Region 1.4.1 Europe Diabetic Therapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Diabetic Therapeutic Drugs (2012-2023) 1.5.1 Europe Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Diabetic Therapeutic Drugs 2.2 Raw Material Analysis of Diabetic Therapeutic Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Diabetic Therapeutic Drugs 2.4 Other Costs Analysis of Diabetic Therapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Diabetic Therapeutic Drugs 2.6 Manufacturing Process Analysis of Diabetic Therapeutic Drugs 2.7 Raw Materials Sources of Diabetic Therapeutic Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Diabetic Therapeutic Drugs Players/Suppliers Profiles and Sales Data 3.1 Pfizer 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Pfizer Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Pfizer Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Pfizer Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.2 Novartis 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Novartis Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Novartis Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Novartis Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.3 AstraZeneca 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 AstraZeneca Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 AstraZeneca Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 AstraZeneca Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Eli Lilly 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Eli Lilly Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Eli Lilly Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Eli Lilly Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Merck 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Merck Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Merck Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Merck Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Novo Nordisk 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Novo Nordisk Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Novo Nordisk Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Novo Nordisk Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Sanofi 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Sanofi Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Sanofi Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Sanofi Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.8 F. Hoffmann-La Roche 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 F. Hoffmann-La Roche Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.9 Takeda Pharmaceuticals 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Takeda Pharmaceuticals Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.10 Sun Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Sun Pharma Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Sun Pharma Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Sun Pharma Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.11 Perle Biosciences 3.12 Arbutus Biopharma 3.13 Belrose Pharma 3.14 Mitsubishi Tanabe Pharma 3.15 Dong-A ST 4 Europe Diabetic Therapeutic Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Diabetic Therapeutic Drugs Market Competition by Players/Manufacturers 4.1.1 Europe Diabetic Therapeutic Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Diabetic Therapeutic Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Diabetic Therapeutic Drugs Sales and Revenue by Type 4.2.1 Europe Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Diabetic Therapeutic Drugs Sales and Revenue by Application 4.3.1 Europe Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Diabetic Therapeutic Drugs Sales (K Units) by Application 5 Germany Diabetic Therapeutic Drugs (Sales, Revenue and Price) 5.1 Germany Diabetic Therapeutic Drugs Sales and Value (2012-2017) 5.1.1 Germany Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Germany Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 5.3 Germany Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 6 UK Diabetic Therapeutic Drugs (Sales, Revenue and Price) 6.1 UK Diabetic Therapeutic Drugs Sales and Value (2012-2017) 6.1.1 UK Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 6.1.3 UK Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 6.3 UK Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 7 France Diabetic Therapeutic Drugs (Sales, Revenue and Price) 7.1 France Diabetic Therapeutic Drugs Sales and Value (2012-2017) 7.1.1 France Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 7.1.3 France Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 7.3 France Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 8 Russia Diabetic Therapeutic Drugs (Sales, Revenue and Price) 8.1 Russia Diabetic Therapeutic Drugs Sales and Value (2012-2017) 8.1.1 Russia Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Russia Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 8.3 Russia Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 9 Benelux Diabetic Therapeutic Drugs (Sales, Revenue and Price) 9.1 Benelux Diabetic Therapeutic Drugs Sales and Value (2012-2017) 9.1.1 Benelux Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 9.3 Benelux Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 10 Italy Diabetic Therapeutic Drugs (Sales, Revenue and Price) 10.1 Italy Diabetic Therapeutic Drugs Sales and Value (2012-2017) 10.1.1 Italy Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Italy Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 10.3 Italy Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 11 Spain Diabetic Therapeutic Drugs (Sales, Revenue and Price) 11.1 Spain Diabetic Therapeutic Drugs Sales and Value (2012-2017) 11.1.1 Spain Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Spain Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 11.3 Spain Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Diabetic Therapeutic Drugs Market Forecast (2018-2023) 13.1 Europe Diabetic Therapeutic Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Diabetic Therapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Diabetic Therapeutic Drugs Price and Trend Forecast (2018-2023) 13.2 Europe Diabetic Therapeutic Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Diabetic Therapeutic Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Diabetic Therapeutic Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Diabetic Therapeutic Drugs Sales Forecast by Type (2018-2023) 13.3.2 Europe Diabetic Therapeutic Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Europe Diabetic Therapeutic Drugs Price Forecast by Type (2018-2023) 13.4 Europe Diabetic Therapeutic Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Diabetic Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Diabetic Therapeutic Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Diabetic Therapeutic Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Diabetic Therapeutic Drugs Table Europe Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Diabetic Therapeutic Drugs Sales (K Units) Market Share by Types in 2017 Figure Insulin Therapies Picture Figure Non-Insulin Therapies Picture Table Europe Diabetic Therapeutic Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Diabetic Therapeutic Drugs by Applications in 2017 Figure Type 1 Diabetes Picture Figure Type 2 Diabetes Picture Figure Gestational Diabetes Picture Table Europe Market Diabetic Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure France Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Europe Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Diabetic Therapeutic Drugs Table Industry News List of Diabetic Therapeutic Drugs Figure Industry Chain Structure of Diabetic Therapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Diabetic Therapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Diabetic Therapeutic Drugs Table Raw Materials Sources of Diabetic Therapeutic Drugs Major Manufacturers Europe Table Major Buyers of Diabetic Therapeutic Drugs Table Pfizer Basic Information List Table Pfizer Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Pfizer Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Pfizer Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Novartis Basic Information List Table Novartis Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Novartis Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Novartis Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table AstraZeneca Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table AstraZeneca Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Eli Lilly Basic Information List Table Eli Lilly Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Eli Lilly Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Eli Lilly Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Merck Basic Information List Table Merck Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Merck Diabetic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Merck Diabetic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Merck Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Merck Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Novo Nordisk Basic Information List Table Novo Nordisk Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novo Nordisk Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Novo Nordisk Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Novo Nordisk Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Sanofi Basic Information List Table Sanofi Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Sanofi Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Sanofi Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table F. Hoffmann-La Roche Basic Information List Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Takeda Pharmaceuticals Basic Information List Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Company Sun Pharma Basic Information List Table Company Sun Pharma Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Sun Pharma Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Company Sun Pharma Diabetic Therapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Company Sun Pharma Diabetic Therapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Sun Pharma Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Company Sun Pharma Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Company Sun Pharma Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Europe Diabetic Therapeutic Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Diabetic Therapeutic Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Diabetic Therapeutic Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Diabetic Therapeutic Drugs Sales Share by Players/Manufacturers Table Europe Diabetic Therapeutic Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Diabetic Therapeutic Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Diabetic Therapeutic Drugs Revenue Market Share (%) Players Figure 2017 Europe Diabetic Therapeutic Drugs Revenue Market Share (%) Players Table Europe Diabetic Therapeutic Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Diabetic Therapeutic Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Diabetic Therapeutic Drugs by Type (2012-2017) Figure Europe Diabetic Therapeutic Drugs Sales Growth Rate (%) by Type (2012-2017) Table Europe Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Diabetic Therapeutic Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Diabetic Therapeutic Drugs by Type (2012-2017) Figure Europe Diabetic Therapeutic Drugs Revenue Growth Rate by Type (2012-2017) Table Europe Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Diabetic Therapeutic Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Diabetic Therapeutic Drugs by Regions (2012-2017) Figure Europe Diabetic Therapeutic Drugs Sales Market Share by Regions in 2017 Table Europe Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Diabetic Therapeutic Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Diabetic Therapeutic Drugs by Regions (2012-2017) Figure Europe Diabetic Therapeutic Drugs Revenue Market Share by Regions in 2017 Table Europe Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017) Table Europe Diabetic Therapeutic Drugs Sales Share (%) by Application (2012-2017) Figure Europe Diabetic Therapeutic Drugs Sales Market Share by Application (2012-2017) Figure Europe Diabetic Therapeutic Drugs Sales Market Share by Application (2012-2017) Figure Germany Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Germany Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Germany Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Germany Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Germany Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Germany Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure UK Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure UK Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table UK Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table UK Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure UK Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table UK Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table UK Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure UK Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure France Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure France Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table France Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table France Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure France Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table France Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table France Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure France Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Russia Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Russia Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Russia Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Russia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Russia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Russia Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Russia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Italy Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Italy Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Italy Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Italy Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Italy Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Italy Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Italy Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Benelux Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Benelux Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Benelux Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Benelux Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Spain Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Spain Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Spain Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Spain Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Spain Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Spain Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Spain Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Diabetic Therapeutic Drugs Price and Trend Forecast (2018-2023) Table Europe Diabetic Therapeutic Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Diabetic Therapeutic Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Diabetic Therapeutic Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Diabetic Therapeutic Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Diabetic Therapeutic Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Diabetic Therapeutic Drugs Revenue Market Share Forecast by Regions in 2023 Figure Germany Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Diabetic Therapeutic Drugs Sales (K Units) Forecast by Type (2018-2023) Figure Europe Diabetic Therapeutic Drugs Sales Market Share Forecast by Type (2018-2023) Table Europe Diabetic Therapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Diabetic Therapeutic Drugs Revenue Market Share Forecast by Type (2018-2023) Table Europe Diabetic Therapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Diabetic Therapeutic Drugs Sales (K Units) Forecast by Application (2018-2023) Figure Europe Diabetic Therapeutic Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Novartis AstraZeneca Eli Lilly Merck Novo Nordisk Sanofi F. Hoffmann-La Roche Takeda Pharmaceuticals Sun Pharma Perle Biosciences Arbutus Biopharma Belrose Pharma Mitsubishi Tanabe Pharma Dong-A ST